Stockreport

Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo [Seeking Alpha]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF with Daiichi Sankyo ( DSKYF ) to obtain exclusive global rights to safusidenib, an experimental brain cancer therapy. The Phase 3 Fresh Stock Ideas, Every Day [Read more]